Drug Trial Radar · NCT06606483
A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight
Last checked: Nov 19, 2026Latest source record: Sep 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
300
Planned (sponsor's estimate)
Start
Sep 23, 2024
Primary completion
Jul 30, 2025
Study completion Sep 30, 2025
Sponsor
- Lead sponsor
- MindRank AI LtdIndustry
- Sponsor type
- Industry
- First posted
- Sep 23, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 24 weeks, multicenter, randomized, double-blind, placebo, parallel-controlled Phase IIb trail comparing the efficacy and safety of MDR-001 tablet versus placebo as an adjunct to a reduced calorie diet and increased physical activity in subjects with overweight or obesity, and to explore the optimal dose selection to support the subsequent Pivotal trial.
Conditions
- Obesity
- Overweight and Obesity
Interventions
MDR-001Drug
Oral administration of small molecule MDR-001 tablets
PlaceboDrug
Administered orally placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change in Body Weight From Baseline at Week 24Time frame: Baseline, Week 24
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
The Second Hospital Of Anhui Medical University
Hefei, Anhui, China
The People's Hospital of Suancheng City
Xuancheng, Anhui, China
Zibo Central Hospital
Zibo, Anhui, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
The Third People's Hospital of Hainan
Haikou, Hainan, China
The Second Hospital Of Hebe Medical University
Shijiazhuang, Hebei, China
The Fourth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
The first Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
The First Affiliated Hospital of Nanyang Medical College
Nanyang, Henan, China
The First People's Hospital of Chenzhou City
Chenzhou, Hunan, China
Zhuzhou Central Hospital
Zhuzhou, Hunan, China
Second Hospital of Jilin University
Changchun, Jilin, China
Daqing People's Hospital
Daqing, Jilin, China
Panjin Liaoyou Gem Flower Hospital
Panjin, Liaoning, China
The Fifth People's Hospital of Shenyang
Shenyang, Liaoning, China
Central hospital of Jinan
Jinan, Shandong, China
Shanxi Bethune Hospital
Taiyuan, Shanxi, China
Xianyan Hospital of Yanan Univisity
Xianyang, Shanxi, China
Yichang Central People's Hospital
Yichang, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.